PACAP 1-27

Catalog No.S8414 Batch:S841402

Technical Data

Formula	C₁₄₂H₂₂₄N₄₀O₃₉S
Molecular Weight	3147.61	CAS No.	127317-03-7
Solubility (25°C)*	In vitro	Water	100 mg/mL (31.77 mM)
		DMSO	Insoluble
		Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

Pituitary adenylate cyclase activating polypeptide (PACAP 1-27) is a potent PACAP receptor antagonist.

Targets

PACAP receptor ^[1]

In vitro

PACAP27(100 nM) inhibits all Tat-mediated toxic effects including DNA DSBs, and it prevents the induction of neuronal loss induced by Tat(transactivator of transcription). PACAP27, through CCL5, mitigates the effects of Tat-induced neuronal dysfunction exerting its neuroprotective effect^[4]. PACAP-27 (EC50=10nM) stimulates glibenclamide-sensitive and DIDS-insensitive iodide efflux in Calu-3 cells^[5].

In vivo

PACAP-27 is potent VIP-like vasodilators of the femoral arterial bed in dogs. In the cardiovascular system, PACAP27 has vasodepressor actions similar to VIP in anesthetized rats. Intra-arterial infusion of PACAP27 induces dose-related increases in peak femoral arterial flow^[3].

Protocol (from reference)

Cell Assay:^{^[2]}	Cell lines The pulmonary carcinoma cell line CALU-6 Concentrations 10 pmol/L to 1 μmol/L Incubation Time 20 h Method Cells are incubated with PACAP (1-27) (10 pmol/L to 1 μmol/L) or forskolin (5 μmol/L) for 20 h. Thereafter, cells are harvested, and isolation of total RNA, reverse transcriptase-PCR, and subsequent determination of renin mRNA and β-actin mRNA expression using real-time PCR.
Animal Study:^{^[3]}	Animal Models beagle dogs Dosages 0.25, 0.5, 1, 2.5, 5, 10, and 25 pmol/kg Administration Intra-arterial infusion

Cell Assay:^{^[2]}

Cell lines
The pulmonary carcinoma cell line CALU-6
Concentrations
10 pmol/L to 1 μmol/L
Incubation Time
20 h
Method
Cells are incubated with PACAP (1-27) (10 pmol/L to 1 μmol/L) or forskolin (5 μmol/L) for 20 h. Thereafter, cells are harvested, and isolation of total RNA, reverse transcriptase-PCR, and subsequent determination of renin mRNA and β-actin mRNA expression using real-time PCR.

Animal Study:^{^[3]}

Animal Models
beagle dogs
Dosages
0.25, 0.5, 1, 2.5, 5, 10, and 25 pmol/kg
Administration
Intra-arterial infusion

References

+ Expand

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.